ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Therabron Therapeutics Receives Orphan Drug Designation in the European Union for CG367, Indicated f
January 24, 2017Therabron Therapeutics, Inc., announced that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products has granted Orphan Drug Designation for Therabron's CG367 program, indicated for the treatment of Bronchiolitis Obliterans Syndrome (B
Pharma Sources Insight January 2025
